Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Seeing optic neuritis through myopic eyes.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
Role of statins in the treatment of multiple sclerosis.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Oral Agent Outcomes
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
A biopsychosocial model of resilience for multiple sclerosis.
Multiple sclerosis: An old drug plays a new trick.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Patient perceptions of multiple sclerosis and its treatment.
Recent Gains in Clinical Multiple Sclerosis Research Review.
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.

Pages